1. Market Research
  2. > Biotechnology Market Trends
Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets

Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets

  • September 2014
  • 122 pages
  • ID: 196578

Summary

Table of Contents

An in-depth analysis of the global nucleic acid aptamer market by technologies, applications and geographic regional markets. This report includes key technologies involved, analyzes the capabilities and characteristics of aptamers in comparison with antibodies and lists specific areas where aptamers could find application. Forecasts are provided through 2019.

Use this report to:
- Define and identify key market segments and market structure in the nucleic acid aptamer market.
- Identify major stakeholders, product portfolios and recent developments, and draw a competitive landscape for market leaders.
- Focus exclusively on geographic segmentation. Analyze trends and opportunities in the major regions: North America, Europe, Asia-Pacific and the Rest of the World (ROW).
- Analyze the inclination of trends toward advanced aptamer technologies such as SELEX technologies and their scope in various applications.

Highlights
- The global market for nucleic acid aptamers reached $340.5 million in 2014. This market should grow to roughly $610.3 million in 2015 and about $5.4 billion in 2019, with a
compound annual growth rate (CAGR) of 73.5% from 2014 to 2019.
- The enabling technology market reached $200.9 million in 2014. This market should grow to $347.9 million in 2015 and $2.7 billion in 2019, with a compound annual growth rate (CAGR) of 68.5%.from 2014 to 2019.
- The diagnostic sensors market reached $139.6 million in 2014. This market should grow to about $262.4 million in 2015 and $2.6 billion in 2019, with a compound annual growth rate (CAGR) of 79.8% from 2014 to 2019.

Introduction & Scope

INTRODUCTION

STUDY GOALS AND OBJECTIVE
- Define and identify key market segments and market structure in the nucleic acid aptamer market.
- Measure and estimate the global nucleic acid aptamer market and its segments, including technology, applications and geographic regions.
- Identify key market dynamics and the factors impacting the global nucleic acid aptamer market and its subsegments.
- Identify the trends, gaps and opportunities in each of the micro markets.
- Focus exclusively on geographic segmentation. Analyze trends and opportunities in the major regions: North America, Europe, Asia-Pacific and the Rest of the World
(ROW).
- Identify major stakeholders, product portfolios and recent developments, and draw a competitive landscape for the market leaders.
- Evaluate key patents and clinical trials in aptamer technologies that are expecting early completion.
- Analyze emerging technologies such as aptasensors and fynomers and derive the opportunities available for these technologies.
- Analyze the inclination of trends toward advanced aptamer technologies such as SELEX technologies and their scope in various applications.

SCOPE OF THE REPORT
This research report presents an in-depth analysis of the global nucleic acid aptamer market by technologies, applications and geographic regional markets. It includes key
technologies involved, analyzes the capabilities and characteristics of aptamers in comparison with antibodies and lists specific areas where aptamers could find application. The evolving trends and technological developments in the field of aptamers have been studied in detail. Special emphasis will be given to collaborative efforts, research innovations and investment clinical trials conducted. Patents will be discussed as well. This study also analyzes the aptamer-based drugs that have been developed or are in the pipeline for the treatment of various diseases. Impact analysis of the key drivers and factors affecting or influencing the growth of this market is also included.

The market for aptamer technologies is further categorized into enabling technology, diagnostic sensors and therapeutics. Enabling technology consists of SELEX technology,
modified oligonucleotides, next-generation sequencing, nanoparticles and quantum dot labels, surface plasmon resonance and biolayer interferometry and bioinformatics. In terms of application the market is classified into diagnostics, therapeutics, research, biosensors, biomarker discovery and others. Furthermore, diagnostics-based aptamers are used in environmental monitoring and food and water safety. They are also used for developing aptasensors for sensing small molecules and pathogens. Aptamers also find application in human clinical diagnostic assays for diagnosing diseases such as cancer, infectious diseases and other immunological diseases.

Aptamers are used in therapeutics and research as drug delivery vehicles in cancer, as a modifier of surgical implants and in bioseparation processes. Research areas include
flow cytometry, mass spectrometry and Western blotting; they are also used as reagents and assays and as biosensors and biomarker molecules. The market is segmented by regions into North America, Europe, Asia-Pacific and ROW. Companies profiled in this report include Ophthotech Corp., Alimera Sciences, AM Biotechnologies LLC, Alnylam Pharmaceuticals, Noxxon, Rina Gmbh, Regado Biosciences, Base Pair Biotechnologies Inc., Aptamer Sciences Inc., Aptasol (Aptamer Solutions) Ltd, Isis Pharmaceuticals, Neoventures Biotechnology Inc., Mitsui & Co. (U.S.A.) Inc., Quest Diagnostics, SomaLogic Inc. and Sumitomo Bakelite Co. Ltd.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Cancer Biomarkers Market by Type, Cancer Type, Profiling Technology, Application - Global Forecast to 2022

Cancer Biomarkers Market: Global Forecast until 2022

  • $ 7150
  • Industry report
  • October 2017
  • by MarketsandMarkets

“Global cancer biomarkers market projected to grow at CAGR of 12.2%”The global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of ...

3D Cell Culture Market by Product, Microfluidics, Magnetic Levitation), Application, End User - Global Forecast to 2022

3D Cell Culture Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

“Global 3D cell culture market projected to grow at a CAGR of 20.3%”The 3D cell culture market is expected to reach USD 1,702.3 million by 2022 from USD 682.8 million in 2017, at a CAGR of 20.3%. The ...

Genomics Market by Product and Services, Technology, Process, Application - Forecast to 2022

Genomics Market: Forecast until 2022

  • $ 5650
  • Industry report
  • October 2017
  • by MarketsandMarkets

“Genomics market is projected to grow at a CAGR of 10.2%”The global genomics market is estimated to grow at a CAGR of 10.2% from 2017 to 2022, to reach USD 23.88 billion in 2022 from 14.71 billion ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.